B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BackgroundVaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to pre...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, Yidan Chen, Bernd Jahrsdörfer, Carolin Ludwig, Hubert Schrezenmeier, Andreia C. Lino, Thomas Dörner
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2022-04-01
Serie:Frontiers in Immunology
Ämnen:
RTX (rituximab)
B-cells
vaccination
SARS – CoV – 2
prediction
Länkar:https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk